Skip to content

Clinical trial on Yashtimadhu Vs Ashwagandha in Stress.

Efficacy of Yashtimadhu In Comparison With Ashwagandha In Stress With Special Reference To Depression Anxiety Stress Scale (DASS-21): A Randomized Control Trial - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080165
Enrollment
82
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F489- Nonpsychotic mental disorder, unspecified

Interventions

None listed

Sponsors

Yogita Pole
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All the patients with symptoms of stress from at least 15 days to 1 year with a score between 15-33 in the DASS-21 Scale. 2.Male and female adults aged between 18 and 65 years. 3.Participants are willing to participate in the study and comply with its procedures by signing a written informed consent.

Exclusion criteria

Exclusion criteria: 1. DASS -21 Score less than 15 and More than 33. 2. Pregnant women and lactating mothers. 3. People with a known hypersensitivity to study medications will be excluded. 4. Patients with serious life-threatening critical illnesses that may interfere with the current study. 5. People reported alcohol dependence and drug abuse. 6. People taking any other investigational drug for another clinical trial/research are also ineligible. 7. Patient with addiction to Narcotics. 8. Patients taking medicines that may interfere with the study outcome. 9. Patients are not willing to participate and are not ready to give written informed consent. 10. Patients having uncontrolled HTN BP > 150/90 mmHg, Known case of Uncontrolled DM with HbA1C >8. 11. The patient taking any other hormonal or psychiatric treatment since last 1 month.

Design outcomes

Primary

MeasureTime frame
Reduction in DASS-21 ScaleTimepoint: Day 0,Day 7, Day 14,Day 21

Secondary

MeasureTime frame
Reduction in PSS ScaleTimepoint: Day 0,Day 7, Day 14,Day 21

Countries

India

Contacts

Public Contactyogita Pole

Government Ayurvedic College and Hospital Nagpur Sakkardara

amitnakanekar@gmail.com9075637847

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026